CRESCENT CAPITAL BDC INC (CCAP)

US2256551092 - Common Stock

17.51  -0.07 (-0.4%)

After market: 17.69 +0.18 (+1.03%)

Fundamental Rating

4

CCAP gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 212 industry peers in the Capital Markets industry. CCAP has a medium profitability rating, but doesn't score so well on its financial health evaluation. CCAP is valued quite cheap, while showing a decent growth score. This is a good combination!



6

1. Profitability

1.1 Basic Checks

In the past year CCAP was profitable.
In the past year CCAP had a positive cash flow from operations.
CCAP had positive earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: CCAP reported negative operating cash flow in multiple years.

1.2 Ratios

CCAP has a better Return On Assets (5.15%) than 64.11% of its industry peers.
The Return On Equity of CCAP (11.29%) is better than 60.29% of its industry peers.
CCAP's Return On Invested Capital of 4.17% is in line compared to the rest of the industry. CCAP outperforms 50.24% of its industry peers.
CCAP had an Average Return On Invested Capital over the past 3 years of 3.66%. This is significantly below the industry average of 10.84%.
The 3 year average ROIC (3.66%) for CCAP is below the current ROIC(4.17%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.15%
ROE 11.29%
ROIC 4.17%
ROA(3y)4.23%
ROA(5y)4.36%
ROE(3y)8.88%
ROE(5y)8.72%
ROIC(3y)3.66%
ROIC(5y)3.65%

1.3 Margins

Looking at the Profit Margin, with a value of 45.53%, CCAP belongs to the top of the industry, outperforming 83.73% of the companies in the same industry.
In the last couple of years the Profit Margin of CCAP has grown nicely.
The Operating Margin of CCAP (45.53%) is better than 77.03% of its industry peers.
In the last couple of years the Operating Margin of CCAP has declined.
CCAP has a Gross Margin (47.36%) which is in line with its industry peers.
CCAP's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 45.53%
PM (TTM) 45.53%
GM 47.36%
OM growth 3Y-11.35%
OM growth 5Y-3.16%
PM growth 3Y-13.74%
PM growth 5Y13.36%
GM growth 3Y-11.9%
GM growth 5Y-4.74%

1

2. Health

2.1 Basic Checks

CCAP has more shares outstanding than it did 1 year ago.
CCAP has more shares outstanding than it did 5 years ago.
CCAP has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 0.51, we must say that CCAP is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.51, CCAP is doing worse than 66.51% of the companies in the same industry.
The Debt to FCF ratio of CCAP is 9.15, which is on the high side as it means it would take CCAP, 9.15 years of fcf income to pay off all of its debts.
CCAP has a Debt to FCF ratio (9.15) which is in line with its industry peers.
A Debt/Equity ratio of 1.14 is on the high side and indicates that CCAP has dependencies on debt financing.
CCAP has a Debt to Equity ratio of 1.14. This is comparable to the rest of the industry: CCAP outperforms 43.54% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.14
Debt/FCF 9.15
Altman-Z 0.51
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 0.20 indicates that CCAP may have some problems paying its short term obligations.
The Current ratio of CCAP (0.20) is worse than 82.30% of its industry peers.
A Quick Ratio of 0.20 indicates that CCAP may have some problems paying its short term obligations.
CCAP has a worse Quick ratio (0.20) than 82.30% of its industry peers.
Industry RankSector Rank
Current Ratio 0.2
Quick Ratio 0.2

5

3. Growth

3.1 Past

CCAP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 32.18%, which is quite impressive.
The Earnings Per Share has been growing by 43.02% on average over the past years. This is a very strong growth
The Revenue has grown by 57.75% in the past year. This is a very strong growth!
Measured over the past years, CCAP shows a very strong growth in Revenue. The Revenue has been growing by 40.78% on average per year.
EPS 1Y (TTM)32.18%
EPS 3Y8.51%
EPS 5Y43.02%
EPS growth Q2Q24.49%
Revenue 1Y (TTM)57.75%
Revenue growth 3Y33.67%
Revenue growth 5Y40.78%
Revenue growth Q2Q44.47%

3.2 Future

CCAP is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -5.49% yearly.
The Revenue is expected to decrease by -3.39% on average over the next years.
EPS Next Y-2.01%
EPS Next 2Y-5.49%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.01%
Revenue Next 2Y-3.39%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

7

4. Valuation

4.1 Price/Earnings Ratio

CCAP is valuated cheaply with a Price/Earnings ratio of 7.61.
Based on the Price/Earnings ratio, CCAP is valued cheaper than 82.30% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 28.11, CCAP is valued rather cheaply.
With a Price/Forward Earnings ratio of 7.77, the valuation of CCAP can be described as very cheap.
Based on the Price/Forward Earnings ratio, CCAP is valued cheaply inside the industry as 82.30% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 20.39. CCAP is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 7.61
Fwd PE 7.77

4.2 Price Multiples

81.34% of the companies in the same industry are more expensive than CCAP, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 7.03
EV/EBITDA N/A

4.3 Compensation for Growth

CCAP has a very decent profitability rating, which may justify a higher PE ratio.
A cheap valuation may be justified as CCAP's earnings are expected to decrease with -5.49% in the coming years.
PEG (NY)N/A
PEG (5Y)0.18
EPS Next 2Y-5.49%
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 9.46%, CCAP is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 7.31, CCAP pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.40, CCAP pays a better dividend.
Industry RankSector Rank
Dividend Yield 9.46%

5.2 History

CCAP has been paying a dividend for over 5 years, so it has already some track record.
As CCAP did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)N/A
Div Incr Years5
Div Non Decr Years5

5.3 Sustainability

CCAP pays out 76.99% of its income as dividend. This is not a sustainable payout ratio.
DP76.99%
EPS Next 2Y-5.49%
EPS Next 3YN/A

CRESCENT CAPITAL BDC INC

NASDAQ:CCAP (5/7/2024, 7:00:02 PM)

After market: 17.69 +0.18 (+1.03%)

17.51

-0.07 (-0.4%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap648.92M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 9.46%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 7.61
Fwd PE 7.77
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)0.18
Profitability
Industry RankSector Rank
ROA 5.15%
ROE 11.29%
ROCE
ROIC
ROICexc
ROICexgc
OM 45.53%
PM (TTM) 45.53%
GM 47.36%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 1.14
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.2
Quick Ratio 0.2
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)32.18%
EPS 3Y8.51%
EPS 5Y
EPS growth Q2Q
EPS Next Y-2.01%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)57.75%
Revenue growth 3Y33.67%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y